The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsutsui, H.
Right arrow Articles by Kaneda, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsutsui, H.
Right arrow Articles by Kaneda, K.

The Journal of Immunology, Vol 157, Issue 9 3967-3973, Copyright © 1996 by American Association of Immunologists

ARTICLES

IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones

H Tsutsui, K Nakanishi, K Matsui, K Higashino, H Okamura, Y Miyazawa and K Kaneda
Section of Immunology, Toneyama Institute for Tuberculosis Research, Osaka, Japan.

NK cells, non-T non-B immune effector lymphocytes, are localized in many organs, including liver, as well as in the circulation. To investigate the regulatory mechanism of killing apparatus in hepatic NK cells, we established IL-2-dependent NK cell clones from liver lymphocytes of BALB/c nude mice. To generate the NK cell clones, we incubated liver lymphocytes with a high dose of IL-2 in the presence of irradiated Kupffer cells, as feeder cells and as the source of IL-12, originally identified as NK cell stimulatory factor. Unless liver lymphocytes were incubated with both IL-2 and Kupffer cells, no cell growth was observed. Hepatic NK cell clones were established from this cell line by limiting dilution. The surface phenotypes of cloned NK cells were IL-2R beta-chain+ CD16+ CD3- IgM-. The clones did not express NK2.1, which is expressed by a half of NK-enriched spleen cells of BALB/c mice. Although the cells contained dense granules reactive to mAb against perforin, they exerted no conventional cytolytic activity against YAC-1. They constitutively expressed Fas ligand (FasL) and specifically killed Fas-positive target cells by fragmenting DNA. This Fas-FasL-mediated killing activity was enhanced by IFN-gamma-inducing factor, a recently identified novel cytokine produced by activated Kupffer cells, but was not affected by other Kupffer cell-produced cytokines, such as IL-12, IL-1beta, and TNF-alpha. Taken together, these findings suggest that hepatic NK cells participate in the immune response as effector cells through the Fas-FasL system in collaboration with cytokines from Kupffer cells.


This article has been cited by other articles:


Home page
 J. Leukoc. Biol.Home page
C. C. Caldwell, J. Tschoep, and A. B. Lentsch
Lymphocyte function during hepatic ischemia/reperfusion injury
J. Leukoc. Biol., September 1, 2007; 82(3): 457 - 464.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. C. Reading, P. G. Whitney, D. P. Barr, M. Wojtasiak, J. D. Mintern, J. Waithman, and A. G. Brooks
IL-18, but not IL-12, Regulates NK Cell Activity following Intranasal Herpes Simplex Virus Type 1 Infection
J. Immunol., September 1, 2007; 179(5): 3214 - 3221.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
V. Pascal, N. R. Nathan, E. Claudio, U. Siebenlist, and S. K. Anderson
NF-{kappa}B p50/p65 Affects the Frequency of Ly49 Gene Expression by NK Cells
J. Immunol., August 1, 2007; 179(3): 1751 - 1759.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
J. Sawaki, H. Tsutsui, N. Hayashi, K. Yasuda, S. Akira, T. Tanizawa, and K. Nakanishi
Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways
Int. Immunol., March 1, 2007; 19(3): 311 - 320.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. Gays, J. G. Aust, D. M. Reid, J. Falconer, N. Toyama-Sorimachi, P. R. Taylor, and C. G. Brooks
Ly49B Is Expressed on Multiple Subpopulations of Myeloid Cells
J. Immunol., November 1, 2006; 177(9): 5840 - 5851.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K. Abdool, E. Cretney, A. D. Brooks, J. M. Kelly, J. Swann, A. Shanker, E. W. Bere Jr., W. M. Yokoyama, J. R. Ortaldo, M. J. Smyth, et al.
NK Cells Use NKG2D to Recognize a Mouse Renal Cancer (Renca), yet Require Intercellular Adhesion Molecule-1 Expression on the Tumor Cells for Optimal Perforin-Dependent Effector Function
J. Immunol., August 15, 2006; 177(4): 2575 - 2583.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. C. Park, S. W. Lee, Y. B. Park, and S. K. Lee
Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis
Rheumatology, May 1, 2006; 45(5): 545 - 548.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
K.-i. Yamanaka, R. Clark, R. Dowgiert, D. Hurwitz, M. Shibata, B. E. Rich, K. Hirahara, D. A. Jones, S. Eapen, H. Mizutani, et al.
Expression of Interleukin-18 and Caspase-1 in Cutaneous T-Cell Lymphoma
Clin. Cancer Res., January 15, 2006; 12(2): 376 - 382.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
Y. Sasaki, T. Yoshimoto, H. Maruyama, T. Tegoshi, N. Ohta, N. Arizono, and K. Nakanishi
IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity
J. Exp. Med., September 6, 2005; 202(5): 607 - 616.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
H. Xu, W. Xu, Y. Chu, Y. Gong, Z. Jiang, and S. Xiong
Involvement of Up-Regulated CXC Chemokine Ligand 16/Scavenger Receptor That Binds Phosphatidylserine and Oxidized Lipoprotein in Endotoxin-Induced Lethal Liver Injury via Regulation of T-Cell Recruitment and Adhesion
Infect. Immun., July 1, 2005; 73(7): 4007 - 4016.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
G. A. Parker and C. A. Picut
Liver Immunobiology
Toxicol Pathol, January 1, 2005; 33(1): 52 - 62.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. J. Smyth, J. Swann, J. M. Kelly, E. Cretney, W. M. Yokoyama, A. Diefenbach, T. J. Sayers, and Y. Hayakawa
NKG2D Recognition and Perforin Effector Function Mediate Effective Cytokine Immunotherapy of Cancer
J. Exp. Med., November 15, 2004; 200(10): 1325 - 1335.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Finotto, J Siebler, M Hausding, M Schipp, S Wirtz, S Klein, M Protschka, A Doganci, H A Lehr, C Trautwein, et al.
Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo
Gut, March 1, 2004; 53(3): 392 - 400.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
H. Oku, Y. Tsuji, S.-I. Kashiwamura, S. Adachi, A. Kubota, H. Okamura, and K. Koyama
Role of IL-18 in pathogenesis of endometriosis
Hum. Reprod., March 1, 2004; 19(3): 709 - 714.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
B. Liu, I. Mori, M. J. Hossain, L. Dong, K. Takeda, and Y. Kimura
Interleukin-18 improves the early defence system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity
J. Gen. Virol., February 1, 2004; 85(2): 423 - 428.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
S. E. Johansson, H. Hall, J. Bjorklund, and P. Hoglund
Broadly impaired NK cell function in non-obese diabetic mice is partially restored by NK cell activation in vivo and by IL-12/IL-18 in vitro
Int. Immunol., January 1, 2004; 16(1): 1 - 11.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
G. Fantuzzi, N. K. Banda, C. Guthridge, A. Vondracek, S.-H. Kim, B. Siegmund, T. Azam, J. A. Sennello, C. A. Dinarello, and W. P. Arend
Generation and characterization of mice transgenic for human IL-18-binding protein isoform a
J. Leukoc. Biol., November 1, 2003; 74(5): 889 - 896.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. T. Wilhelm, J.-R. Landry, F. Takei, and D. L. Mager
Transcriptional Control of Murine CD94 Gene: Differential Usage of Dual Promoters by Lymphoid Cell Types
J. Immunol., October 15, 2003; 171(8): 4219 - 4226.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Kikuchi-Maki, S.-i. Yusa, T. L. Catina, and K. S. Campbell
KIR2DL4 Is an IL-2-Regulated NK Cell Receptor That Exhibits Limited Expression in Humans but Triggers Strong IFN-{gamma} Production
J. Immunol., October 1, 2003; 171(7): 3415 - 3425.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. C. Reading and G. L. Smith
Vaccinia Virus Interleukin-18-Binding Protein Promotes Virulence by Reducing Gamma Interferon Production and Natural Killer and T-Cell Activity
J. Virol., September 15, 2003; 77(18): 9960 - 9968.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Plitz, P. Saint-Mezard, M. Satho, S. Herren, C. Waltzinger, M. de Carvalho Bittencourt, M. H. Kosco-Vilbois, and Y. Chvatchko
IL-18 Binding Protein Protects Against Contact Hypersensitivity
J. Immunol., August 1, 2003; 171(3): 1164 - 1171.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Y. Luo, H. Zhou, M. Mizutani, N. Mizutani, R. A. Reisfeld, and R. Xiang
Transcription factor Fos-related antigen 1 is an effective target for a breast cancer vaccine
PNAS, July 22, 2003; 100(15): 8850 - 8855.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
H. Nakano, H. Tsutsui, M. Terada, K. Yasuda, K. Matsui, S. Yumikura-Futatsugi, K.-i. Yamanaka, H. Mizutani, T. Yamamura, and K. Nakanishi
Persistent secretion of IL-18 in the skin contributes to IgE response in mice
Int. Immunol., May 1, 2003; 15(5): 611 - 621.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
J. A. Gracie, S. E. Robertson, and I. B. McInnes
Interleukin-18
J. Leukoc. Biol., February 1, 2003; 73(2): 213 - 224.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
P. Kaiser, G. Underwood, and F. Davison
Differential Cytokine Responses following Marek's Disease Virus Infection of Chickens Differing in Resistance to Marek's Disease
J. Virol., December 11, 2002; 77(1): 762 - 768.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. M. Wigginton, J.-K. Lee, T. A. Wiltrout, W. G. Alvord, J. A. Hixon, J. Subleski, T. C. Back, and R. H. Wiltrout
Synergistic Engagement of an Ineffective Endogenous Anti-Tumor Immune Response and Induction of IFN-{gamma} and Fas-Ligand-Dependent Tumor Eradication by Combined Administration of IL-18 and IL-2
J. Immunol., October 15, 2002; 169(8): 4467 - 4474.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
H. Konishi, H. Tsutsui, T. Murakami, S. Yumikura-Futatsugi, K.-i. Yamanaka, M. Tanaka, Y. Iwakura, N. Suzuki, K. Takeda, S. Akira, et al.
IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions
PNAS, August 20, 2002; 99(17): 11340 - 11345.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Hedtjarn, A.-L. Leverin, K. Eriksson, K. Blomgren, C. Mallard, and H. Hagberg
Interleukin-18 Involvement in Hypoxic-Ischemic Brain Injury
J. Neurosci., July 15, 2002; 22(14): 5910 - 5919.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
A. Ariel, D. Novick, M. Rubinstein, C. A. Dinarello, O. Lider, and R. Hershkoviz
IL-12 and IL-18 induce MAP kinase-dependent adhesion of T cells to extracellular matrix components
J. Leukoc. Biol., July 1, 2002; 72(1): 192 - 198.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Saleh, A. P. Makrigiannis, D. L. Hodge, and S. K. Anderson
Identification of a Novel Ly49 Promoter That Is Active in Bone Marrow and Fetal Thymus
J. Immunol., May 15, 2002; 168(10): 5163 - 5169.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
D. Arnold, C. Wasem, P. Juillard, P. Graber, I. Cima, C. Frutschi, S. Herren, S. Jakob, S. Alouani, C. Mueller, et al.
IL-18-independent cytotoxic T lymphocyte activation and IFN-{gamma} production during experimental acute graft-versus-host disease
Int. Immunol., May 1, 2002; 14(5): 503 - 511.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. P. Singh, S.-i. Kashiwamura, P. Rao, H. Okamura, A. Mukherjee, and V. S. Chauhan
The Role of IL-18 in Blood-Stage Immunity Against Murine Malaria Plasmodium yoelii265 and Plasmodium bergheiANKA
J. Immunol., May 1, 2002; 168(9): 4674 - 4681.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
P. Kaiser, L. Rothwell, D. Vasicek, and K. Hala
A Role for IL-15 in Driving the Onset of Spontaneous Autoimmune Thyroiditis?
J. Immunol., April 15, 2002; 168(8): 4216 - 4220.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
K. Shimoda, H. Tsutsui, K. Aoki, K. Kato, T. Matsuda, A. Numata, K. Takase, T. Yamamoto, H. Nukina, T. Hoshino, et al.
Partial impairment of interleukin-12 (IL-12) and IL-18 signaling in Tyk2-deficient mice
Blood, March 15, 2002; 99(6): 2094 - 2099.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
F. N. Lauw, J. Branger, S. Florquin, P. Speelman, S. J. H. van Deventer, S. Akira, and T. van der Poll
IL-18 Improves the Early Antimicrobial Host Response to Pneumococcal Pneumonia
J. Immunol., January 1, 2002; 168(1): 372 - 378.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Paulukat, M. Bosmann, M. Nold, S. Garkisch, H. Kampfer, S. Frank, J. Raedle, S. Zeuzem, J. Pfeilschifter, and H. Muhl
Expression and Release of IL-18 Binding Protein in Response to IFN-{gamma}
J. Immunol., December 15, 2001; 167(12): 7038 - 7043.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Sugawara, A. Uehara, T. Nochi, T. Yamaguchi, H. Ueda, A. Sugiyama, K. Hanzawa, K. Kumagai, H. Okamura, and H. Takada
Neutrophil Proteinase 3-Mediated Induction of Bioactive IL-18 Secretion by Human Oral Epithelial Cells
J. Immunol., December 1, 2001; 167(11): 6568 - 6575.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Faggioni, R. C. Cattley, J. Guo, S. Flores, H. Brown, M. Qi, S. Yin, D. Hill, S. Scully, C. Chen, et al.
IL-18-Binding Protein Protects Against Lipopolysaccharide- Induced Lethality and Prevents the Development of Fas/Fas Ligand-Mediated Models of Liver Disease in Mice
J. Immunol., November 15, 2001; 167(10): 5913 - 5920.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
M. Neighbors, X. Xu, F. J. Barrat, S. R. Ruuls, T. Churakova, R. Debets, J. F. Bazan, R. A. Kastelein, J. S. Abrams, and A. O'Garra
A Critical Role for Interleukin 18 in Primary and Memory Effector Responses to Listeria monocytogenes that Extends Beyond its Effects on Interferon {gamma} Production
J. Exp. Med., August 6, 2001; 194(3): 343 - 354.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Nakahira, M. Tomura, M. Iwasaki, H.-J. Ahn, Y. Bian, T. Hamaoka, T. Ohta, M. Kurimoto, and H. Fujiwara
An Absolute Requirement for STAT4 and a Role for IFN-{gamma} as an Amplifying Factor in IL-12 Induction of the Functional IL-18 Receptor Complex
J. Immunol., August 1, 2001; 167(3): 1306 - 1312.
[Abstract] [Full Text] [PDF]

Home page
 J. Leukoc. Biol.Home page
L. Yao, J. Setsuda, C. Sgadari, B. Cherney, and G. Tosato
Interleukin-18 expression induced by Epstein-Barr virus-infected cells
J. Leukoc. Biol., May 1, 2001; 69(5): 779 - 784.
[Abstract] [Full Text]

Home page
 Int ImmunolHome page
T. Okazaki, S. Ozaki, T. Nagaoka, M. Kozuki, S. Sumita, M. Tanaka, F. Osakada, M. Kishimura, T. Kakutani, and K. Nakao
Antigen-specific Th1 cells as direct effectors of Propionibacterium acnes-primed lipopolysaccharide-induced hepatic injury
Int. Immunol., May 1, 2001; 13(5): 607 - 613.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Z.-X. Liu, S. Govindarajan, S. Okamoto, and G. Dennert
Fas-Mediated Apoptosis Causes Elimination of Virus-Specific Cytotoxic T Cells in the Virus-Infected Liver
J. Immunol., March 1, 2001; 166(5): 3035 - 3041.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H.-R. Jiang, X.-q. Wei, W. Niedbala, L. Lumsden, F. Y. Liew, and J. V. Forrester
IL-18 Not Required for IRBP Peptide-Induced EAU: Studies in Gene-Deficient Mice
Invest. Ophthalmol. Vis. Sci., January 1, 2001; 42(1): 177 - 182.
[Abstract] [Full Text]

Home page
 Infect. Immun.Home page
J. K. Brieland, C. Jackson, S. Hurst, D. Loebenberg, T. Muchamuel, R. Debets, R. Kastelein, T. Churakova, J. Abrams, R. Hare, et al.
Immunomodulatory Role of Endogenous Interleukin-18 in Gamma Interferon-Mediated Resolution of Replicative Legionella pneumophila Lung Infection
Infect. Immun., December 1, 2000; 68(12): 6567 - 6573.
[Abstract] [Full Text] [PDF]

Home page
 GutHome page
S Chikano, K Sawada, T Shimoyama, S-I Kashiwamura, A Sugihara, K Sekikawa, N Terada, K Nakanishi, and H Okamura
IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner
Gut, December 1, 2000; 47(6): 779 - 786.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. Debets, J. C. Timans, T. Churakowa, S. Zurawski, R. de Waal Malefyt, K. W. Moore, J. S. Abrams, A. O'Garra, J. F. Bazan, and R. A. Kastelein
IL-18 Receptors, Their Role in Ligand Binding and Function: Anti-IL-1RAcPL Antibody, a Potent Antagonist of IL-18
J. Immunol., November 1, 2000; 165(9): 4950 - 4956.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
Y.-M. Kim, J. Y. Im, S. H. Han, H. S. Kang, and I. Choi
IFN-{gamma} Up-Regulates IL-18 Gene Expression Via IFN Consensus Sequence-Binding Protein and Activator Protein-1 Elements in Macrophages
J. Immunol., September 15, 2000; 165(6): 3198 - 3205.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
B. R. Lauwerys, N. Garot, J.-C. Renauld, and F. A. Houssiau
Cytokine Production and Killer Activity of NK/T-NK Cells Derived with IL-2, IL-15, or the Combination of IL-12 and IL-18
J. Immunol., August 15, 2000; 165(4): 1847 - 1853.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Sareneva, I. Julkunen, and S. Matikainen
IFN-{alpha} and IL-12 Induce IL-18 Receptor Gene Expression in Human NK and T Cells
J. Immunol., August 15, 2000; 165(4): 1933 - 1938.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
U. Kalina, D. Kauschat, N. Koyama, H. Nuernberger, K. Ballas, S. Koschmieder, G. Bug, W.-K. Hofmann, D. Hoelzer, and O. G. Ottmann
IL-18 Activates STAT3 in the Natural Killer Cell Line 92, Augments Cytotoxic Activity, and Mediates IFN-{gamma} Production by the Stress Kinase p38 and by the Extracellular Regulated Kinases p44erk-1 and p42erk-21
J. Immunol., August 1, 2000; 165(3): 1307 - 1313.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
K.-i. Yamanaka, M. Tanaka, H. Tsutsui, T. S. Kupper, K. Asahi, H. Okamura, K. Nakanishi, M. Suzuki, N. Kayagaki, R. A. Black, et al.
Skin-Specific Caspase-1-Transgenic Mice Show Cutaneous Apoptosis and Pre-Endotoxin Shock Condition with a High Serum Level of IL-18
J. Immunol., July 15, 2000; 165(2): 997 - 1003.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
C. LORZ, A. ORTIZ, P. JUSTO, S. GONZÁLEZ-CUADRADO, N. DUQUE, C. GÓMEZ-GUERRERO, and J. EGIDO
Proapoptotic Fas Ligand Is Expressed by Normal Kidney Tubular Epithelium and Injured Glomeruli
J. Am. Soc. Nephrol., July 1, 2000; 11(7): 1266 - 1277.
[Abstract] [Full Text]

Home page
 Infect. Immun.Home page
P. Hochholzer, G. B. Lipford, H. Wagner, K. Pfeffer, and K. Heeg
Role of Interleukin-18 (IL-18) during Lethal Shock: Decreased Lipopolysaccharide Sensitivity but Normal Superantigen Reaction in IL-18-Deficient Mice
Infect. Immun., June 1, 2000; 68(6): 3502 - 3508.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
P. G. Arndt, G. Fantuzzi, and E. Abraham
Expression of Interleukin-18 in the Lung after Endotoxemia or Hemorrhage-Induced Acute Lung Injury
Am. J. Respir. Cell Mol. Biol., June 1, 2000; 22(6): 708 - 713.
[Abstract] [Full Text]

Home page
 Infect. Immun.Home page
K. Ohkusu, T. Yoshimoto, K. Takeda, T. Ogura, S.-i. Kashiwamura, Y. Iwakura, S. Akira, H. Okamura, and K. Nakanishi
Potentiality of Interleukin-18 as a Useful Reagent for Treatment and Prevention of Leishmania major Infection
Infect. Immun., May 1, 2000; 68(5): 2449 - 2456.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. Cho, H. Song, Y. M. Kim, D. Houh, D. Y. Hur, H. Park, D. Yoon, K. H. Pyun, W. J. Lee, M. Kurimoto, et al.
Endogenous Interleukin-18 Modulates Immune Escape of Murine Melanoma Cells by Regulating the Expression of Fas Ligand and Reactive Oxygen Intermediates
Cancer Res., May 1, 2000; 60(10): 2703 - 2709.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
T. L. Born, L. A. Morrison, D. J. Esteban, T. VandenBos, L. G. Thebeau, N. Chen, M. K. Spriggs, J. E. Sims, and R. M. L. Buller
A Poxvirus Protein That Binds to and Inactivates IL-18, and Inhibits NK Cell Response
J. Immunol., March 15, 2000; 164(6): 3246 - 3254.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
K. Tominaga, T. Yoshimoto, K. Torigoe, M. Kurimoto, K. Matsui, T. Hada, H. Okamura, and K. Nakanishi
IL-12 synergizes with IL-18 or IL-1{beta} for IFN-{gamma} production from human T cells
Int. Immunol., February 1, 2000; 12(2): 151 - 160.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
T. Kaisho, H. Tsutsui, T. Tanaka, T. Tsujimura, K. Takeda, T. Kawai, N. Yoshida, K. Nakanishi, and S. Akira
Impairment of Natural Killer Cytotoxic Activity and Interferon {gamma} Production in CCAAT/Enhancer Binding Protein {gamma}-deficient Mice
J. Exp. Med., December 6, 1999; 190(11): 1573 - 1582.
[Abstract] [Full Text] [PDF]

Home page